D-0220-2016 Class II Terminated

Recalled by The Compounder — Aurora, IL

FDA drug recall D-0220-2016 was initiated by The Compounder on Mar 10, 2015 and is designated Class II. Reason for recall: Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination. The recall status is terminated (terminated May 19, 2016). Affected quantity: 30 (3mL) syringes.

Recall Details

Product Type
Drugs
Report Date
Nov 18, 2015
Initiation Date
Mar 10, 2015
Termination Date
May 19, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30 (3mL) syringes

Product Description

ESTRIOL (E3) : TESTO (Testosterone USP) WV (weight/volume) 0.5MG : 2MG/ML Transdermal cream, dispensed in 3 mL prefilled, amber syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Reason for Recall

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Distribution Pattern

Nationwide

Code Information

Lot # 12292014:45@12, Exp 6/27/2015; Lot # 01282015:06@16, Exp 7/27/2015; Lot # 03022015:06@38, Exp 8/29/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0220-2016
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.